Medicines up 3% on Q1 results

|About: The Medicines Company (MDCO)|By:, SA News Editor

Medicines (MDCO) Q1 results: Revenues: $0; R&D Expense: $27M (-33.2%); SG&A: $17M (-41.4%); Net Loss: ($59.9M) (+29.4%); Loss Per Share: ($0.80) (+30.4%); Non-GAAP Net Loss: ($46M) (+18.4%); Non-GAAP Loss Per Share: ($0.62) (+18.4%).

Shares are up 3% premarket.

Previously: Medicines misses by $0.08 (April 25)

Subscribe for full text news in your inbox